19-49035893-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_033377.2(CGB1):āc.185T>Gā(p.Val62Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000169 in 1,227,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000027 ( 0 hom., cov: 25)
Exomes š: 0.00017 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CGB1
NM_033377.2 missense
NM_033377.2 missense
Scores
6
5
5
Clinical Significance
Conservation
PhyloP100: 5.19
Genes affected
CGB1 (HGNC:16721): (chorionic gonadotropin subunit beta 1) The beta subunit of chorionic gonadotropin (CGB) is encoded by six highly homologous and structurally similar genes that are arranged in tandem and inverted pairs on chromosome 19q13.3, and contiguous with the luteinizing hormone beta (LHB) subunit gene. The CGB genes are primarily distinguished by differences in the 5' untranscribed region. This gene was originally thought to be one of the two pseudogenes (CGB1 and CGB2) of CGB subunit, however, detection of CGB1 and CGB2 transcripts in vivo, and their presence on the polysomes, suggested that these transcripts are translated. To date, a protein product corresponding to CGB1 has not been isolated. The deduced sequence of the hypothetical protein of 132 aa does not share any similarity with that of functional CGB subunits (PMID:8954017). However, a 155 aa protein, translated from a different frame, is about the same size, and shares 98% identity with other CGB subunits. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.859
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CGB1 | ENST00000301407.8 | c.185T>G | p.Val62Gly | missense_variant | 3/3 | 1 | NM_033377.2 | ENSP00000301407.6 | ||
ENSG00000267335 | ENST00000591656.1 | c.-28+633T>G | intron_variant | 2 | ENSP00000466140.1 | |||||
ENSG00000267335 | ENST00000604577.1 | c.9+810T>G | intron_variant | 1 | ENSP00000474022.1 | |||||
CGB1 | ENST00000601167.1 | c.149T>G | p.Val50Gly | missense_variant | 3/3 | 5 | ENSP00000472896.2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 4AN: 145754Hom.: 0 Cov.: 25 FAILED QC
GnomAD3 genomes
AF:
AC:
4
AN:
145754
Hom.:
Cov.:
25
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000169 AC: 208AN: 1227834Hom.: 0 Cov.: 22 AF XY: 0.000175 AC XY: 106AN XY: 605980
GnomAD4 exome
AF:
AC:
208
AN:
1227834
Hom.:
Cov.:
22
AF XY:
AC XY:
106
AN XY:
605980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000274 AC: 4AN: 145754Hom.: 0 Cov.: 25 AF XY: 0.0000424 AC XY: 3AN XY: 70832
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
4
AN:
145754
Hom.:
Cov.:
25
AF XY:
AC XY:
3
AN XY:
70832
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2023 | The c.185T>G (p.V62G) alteration is located in exon 3 (coding exon 3) of the CGB1 gene. This alteration results from a T to G substitution at nucleotide position 185, causing the valine (V) at amino acid position 62 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.
REVEL
Uncertain
Sift
Pathogenic
D;.
Sift4G
Uncertain
D;.
Polyphen
D;.
Vest4
MutPred
Loss of stability (P = 0.0078);.;
MVP
MPC
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at